查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941779

麻醉設備市場規模、佔有率和趨勢分析報告：按產品、最終用途、地區和細分市場預測，2026-2033年

Anesthesia Devices Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

麻醉設備市場概述

全球麻醉設備市場預計到 2025 年將價值 246 億美元，預計到 2033 年將達到 303 億美元。

預計從 2026 年到 2033 年，該市場將以 2.26% 的複合年成長率成長。市場成長的促進因素包括全球外科手術數量的增加、慢性疾病的流行以及麻醉工作站顯示器的技術進步。

主要製造商經常推出新產品和改進現有產品，加速了兒童和手術中心對技術應用和升級的需求，推動了麻醉設備產業的成長。主要企業不斷推出新一代麻醉工作站，這些工作站具備增強的安全功能、先進的通氣模式、更符合人體工學的設計、數位整合以及對永續性的重視，以滿足成人、兒科和新生兒護理中不斷變化的臨床需求。例如：

  • 2025 年 10 月，GE 醫療在 2025 年麻醉學大會上推出了 Carestation 850 麻醉輸送系統，該系統採用符合人體工學的設計、可自訂的應用程式、先進的汽化功能、永續性工具和直覺的用戶介面，旨在提高從新生兒到成人等各種患者的精準度和效率。

「在瞬息萬變的外科手術環境中，麻醉專業人員需要應對日益複雜的病例和不斷變化的患者需求，同時始終將安全放在首位。隨著麻醉護理團隊面臨新的挑戰，技術可以幫助減輕他們的負擔，並提供更安全、更有效的護理。”

約翰·比爾德醫學博士，通用電氣醫療集團患者照護解決方案首席醫療官；麻醉師

  • 2025年9月，Medicis在德里國際醫療展上發布了印度製造的COSMOS麻醉工作站。該工作站配備了新生兒專用技術，例如15英寸先進介面、整合式病患監測和LED照光治療。產品設計以病人安全、臨床操作便利性和環境效率為首要考量。

這些持續的創新正在擴大麻醉設備的臨床應用範圍，幫助其符合更嚴格的安全性和效率標準，並鼓勵醫療保健提供者升級舊系統，從而推動整體市場成長和對先進麻醉工作站的長期需求。

麻醉設備市場的一個顯著新興趨勢是人工智慧 (AI) 和智慧軟體的融合，這正在改變麻醉護理的模式。人工智慧演算法支援智慧通氣管理，能夠利用即時患者數據最佳化麻醉氣體輸送，透過預測性警報預測不利事件，並透過自動化和決策支援減輕醫護人員的認知負荷。

這些功能還有助於提高工作流程效率，實現成人、兒童和新生兒護理的標準化，並增強與手術全期IT系統的互通性。例如，2026年1月，GE醫療與恩智浦半導體合作，共同開發急診的邊緣人工智慧解決方案。這些解決方案在2026年國際消費電子展（CES 2026）上展出，包括語音活化麻醉管理系統（可減輕醫護人員的認知負荷）和用於新生兒加護病房（NICU）的即時新生兒監護系統。此次合作充分利用了恩智浦的安全邊緣處理器和GE醫療的醫療技術專長，在手術室和其他先進醫療環境中實現了低延遲、注重隱私的人工智慧。人工智慧的日益普及使麻醉設備更加智慧、安全和高效，加速了先進麻醉系統在現代醫療機構中的應用。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 麻醉設備市場變數、趨勢與範圍

  • 市場動態
  • 麻醉設備市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析

第4章 麻醉設備市場：依產品分類的估算與趨勢分析

  • 按產品類型分類的市場佔有率（2025 年和 2033 年）
  • 全球麻醉設備市場：按產品類型分類的展望
  • 麻醉機
    • 麻醉工作站
    • 麻醉輸送裝置
    • 麻醉人工呼吸器
    • 麻醉監控器
  • 麻醉耗材
    • 麻醉面罩
    • 麻醉配件

第5章 麻醉設備市場：依最終用途分類的估算與趨勢分析

  • 按最終用途分類的市場佔有率（2025 年和 2033 年）
  • 全球麻醉設備市場：按最終用途分類的展望
  • 醫院
  • 門診治療中心
  • 其他

第6章：麻醉設備市場：區域估算與趨勢分析

  • 區域市場佔有率分析（2025 年和 2033 年）
  • 區域市場概覽
  • 全球市場概覽（按地區分類）
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭情勢

  • 對主要市場參與企業近期趨勢和影響的分析
  • 公司/競爭對手分類
  • 主要企業市佔率和地位分析（2025 年）
  • 公司簡介
    • GE Healthcare
    • Dragerwerk AG &Co. KGaA
    • Mindray Bio-Medical Electronics Co., Ltd.
    • Medtronic
    • Koninklijke Philips NV
    • Beijing Aeonmed Co., Ltd.
    • Spacelabs Healthcare acquired by OSI Systems, Inc.
    • Getinge AB
    • Penlon
    • Heal Force Bio-Meditech Holdings Limited
    • Shenzhen Northern Meditec Limited
    • Shanghai Huifeng Medical Instrument Co., Ltd.
    • Shenzhen Comen Medical Instruments Co., Ltd.
    • BPL Medical Technologies
    • aXcent medical
Product Code: GVR-4-68040-841-4

Anesthesia Devices Market Summary

The global anesthesia devices market size was estimated at USD 24.6 billion in 2025 and is projected to reach USD 30.3 billion by 2033, growing at a CAGR of 2.26% from 2026 to 2033. The market growth is driven by the increasing number of surgical procedures worldwide, the prevalence of chronic diseases, and technological advancements in anesthesia workstations and monitors

Increasing frequency of new and upgraded product launches by leading manufacturers is accelerating technology adoption and replacement demand across hospitals and surgical centers, contributing to the growth of the anesthesia machines industry. Major players are continuously introducing next-generation anesthesia workstations with enhanced safety features, advanced ventilation modes, improved ergonomics, digital integration, and sustainability-focused designs, addressing evolving clinical requirements across adult, pediatric, and neonatal care. For instance:

  • In October 2025, GE HealthCare launched the Carestation 850 anesthesia delivery system at ANESTHESIOLOGY 2025, featuring ergonomic design, customizable apps, advanced vaporization, sustainability tools, and intuitive UI to enhance precision and efficiency for diverse patients from neonates to adults.

"In the dynamic operating environment, anesthesia professionals are focused on safety while managing increasingly complex cases and changing patient needs. As anesthesia care teams face new challenges, technology can help ease the burden and support safer and more effective care delivery."

John Beard, MD, anesthesiologist and Chief Medical Officer of Patient Care Solutions at GE HealthCare.

  • In September 2025, Medisys launched the Made-in-India COSMOS anesthesia workstation, featuring a 15-inch advanced interface, integrated patient monitoring, and neonatal technology such as LED Phototherapy, at Medicall Delhi. This launch prioritized patient safety, clinician usability, and eco-friendly efficiency.

Such continuous innovation expands the clinical applicability of anesthesia machines, supports compliance with stricter safety and efficiency standards, and encourages healthcare providers to upgrade legacy systems, thereby strongly driving overall market growth and long-term demand for advanced anesthesia workstations.

A significant emerging trend in the anesthesia devices market is the integration of artificial intelligence (AI) and smart software, which is transforming the delivery of anesthesia care. AI-enabled algorithms support intelligent ventilation management, optimize anesthetic gas delivery using real-time patient data, enable predictive alarms to anticipate adverse events, and reduce clinician cognitive burden through automation and decision support.

These capabilities also improve workflow efficiency, standardize care across adult, pediatric, and neonatal populations, and enhance interoperability with perioperative IT systems. For instance, in January 2026, GE HealthCare collaborated with NXP Semiconductors to develop edge AI solutions for acute care, including voice-activated anesthesia delivery systems to reduce clinician cognitive load and real-time neonatal monitoring for NICUs, showcased at CES 2026; the partnership leverages NXP's secure edge processors and GE HealthCare's medical technology expertise to deliver low-latency, privacy-focused AI in operating rooms and other high-acuity settings. Thus, the growing integration of AI is making anesthesia devices smarter, safer, and more efficient, thereby accelerating the adoption of advanced anesthesia systems across modern healthcare facilities.

Global Anesthesia Devices Market Report Segmentation

This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global anesthesia devices market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Anesthesia Machines
    • Anesthesia Workstation
    • Anesthesia delivery machines
    • Portable
    • Standalone
    • Anesthesia Ventilators
    • Anesthesia Monitors
  • Anesthesia Disposables
    • Anesthesia Masks
    • Anesthesia Accessories
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product outlook
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End Use
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Anesthesia Devices Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market Driver analysis
      • 3.1.1.1. Increasing number of surgical procedures worldwide
      • 3.1.1.2. Rising prevalence of chronic diseases requiring surgery
      • 3.1.1.3. Growth of ambulatory surgery and day-care centers
      • 3.1.1.4. Technological advancements in anesthesia workstations and monitors
    • 3.1.2. Market Restraint Analysis
      • 3.1.2.1. High capital cost of advanced anesthesia workstations
      • 3.1.2.2. High maintenance and servicing costs
    • 3.1.3. Market Opportunities
    • 3.1.4. Market Challenges
    • 3.1.5. Emerging Trends
  • 3.2. Anesthesia Devices Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape

Chapter 4. Anesthesia Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Type Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Anesthesia Devices Market by Product Type Outlook
  • 4.4. Anesthesia Machines
    • 4.4.1. Anesthesia Machines market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Anesthesia Workstation
      • 4.4.2.1. Anesthesia Workstation market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Anesthesia Delivery Machines
      • 4.4.3.1. Anesthesia Delivery Machines market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Portable Anesthesia Delivery Station
        • 4.4.3.2.1. Portable Anesthesia Delivery Machines market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Standalone Anesthesia Delivery Station
        • 4.4.3.3.1. Standalone Anesthesia Delivery Machines market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Anesthesia Ventilators
      • 4.4.4.1. Anesthesia Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Anesthesia Monitors
      • 4.4.5.1. Anesthesia Monitors market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Anesthesia Disposables
    • 4.5.1. Anesthesia Disposables market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Anesthesia Masks
      • 4.5.2.1. Anesthesia Masks market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Anesthesia Accessories
      • 4.5.3.1. Anesthesia Accessories market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Anesthesia Devices Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Type Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Anesthesia Devices Market by End Use Outlook
  • 5.4. Hospitals
    • 5.4.1. Hospitals' market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Ambulatory Centers
    • 5.5.1. Ambulatory Centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Anesthesia Devices Market: Regional Estimates & Trend Analysis, By Product & End Use

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share/position analysis, 2025
  • 7.4. Company Profiles
    • 7.4.1. GE Healthcare
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Dragerwerk AG & Co. KGaA
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Mindray Bio-Medical Electronics Co., Ltd.
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Medtronic
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Koninklijke Philips N.V.
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Beijing Aeonmed Co., Ltd.
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Spacelabs Healthcare acquired by OSI Systems, Inc.
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Getinge AB
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Penlon
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Heal Force Bio-Meditech Holdings Limited
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Shenzhen Northern Meditec Limited
      • 7.4.11.1. Company Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Shanghai Huifeng Medical Instrument Co., Ltd.
      • 7.4.12.1. Company Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Strategic initiatives
    • 7.4.13. Shenzhen Comen Medical Instruments Co., Ltd.
      • 7.4.13.1. Company Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Strategic initiatives
    • 7.4.14. BPL Medical Technologies
      • 7.4.14.1. Company Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Strategic initiatives
    • 7.4.15. aXcent medical
      • 7.4.15.1. Company Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Strategic initiatives

List of Tables

  • Table 1 North America Anesthesia Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 2 North America Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 3 North America Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 4 U.S. Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 U.S. Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 6 Canada Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 7 Canada Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 Mexico Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 9 Mexico Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 10 Europe Anesthesia Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 11 Europe Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 12 Europe Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 UK Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 UK Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 15 Germany Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 16 Germany Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 France Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 18 France Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 19 Italy Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 20 Italy Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Spain Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Spain Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 Sweden Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 24 Sweden Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Denmark Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 26 Denmark Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 27 Norway Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 28 Norway Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific Anesthesia Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific Anesthesia Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 31 Asia Pacific Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 32 China Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 33 China Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Japan Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 Japan Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 India Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 37 India Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 Australia Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 39 Australia Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 40 South Korea Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 41 South Korea Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Thailand Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Thailand Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44 Latin America Anesthesia Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 45 Latin America Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 46 Latin America Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 47 Brazil Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 48 Brazil Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 49 Argentina Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 50 Argentina Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 51 MEA Anesthesia Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 52 MEA Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 53 MEA Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 South Africa Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 55 South Africa Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 56 Saudi Arabia Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 57 Saudi Arabia Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 UAE Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 UAE Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 60 Kuwait Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 61 Kuwait Devices Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Aesthesia devices market outlook
  • Fig. 9 Aesthesia devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Aesthesia devices market driver impact
  • Fig. 15 Aesthesia devices market restraint impact
  • Fig. 16 Aesthesia devices market strategic initiatives analysis
  • Fig. 17 Aesthesia devices market: Product movement analysis
  • Fig. 18 Aesthesia devices market: Product outlook and key takeaways
  • Fig. 19 Anesthesia machines market, 2021 - 2033 (USD Million)
  • Fig. 20 Anesthesia delivery machines market, 2021 - 2033 (USD Million)
  • Fig. 21 Anesthesia monitors market, 2021 - 2033 (USD Million)
  • Fig. 22 Anesthesia ventilators market, 2021 - 2033 (USD Million)
  • Fig. 23 Anesthesia workstations market, 2021 - 2033 (USD Million)
  • Fig. 24 Anesthesia disposables market, 2021 - 2033 (USD Million)
  • Fig. 25 Anesthesia disposables masks market, 2021 - 2033 (USD Million)
  • Fig. 26 Anesthesia disposable accessories market, 2021 - 2033 (USD Million)
  • Fig. 27 Aesthesia devices market: End Use movement analysis
  • Fig. 28 Aesthesia devices market: End Use outlook and key takeaways
  • Fig. 29 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 30 Ambulatory Centers market, 2021 - 2033 (USD Million)
  • Fig. 31 Others market, 2021 - 2033 (USD Million)
  • Fig. 32 Global aesthesia devices market: Regional movement analysis
  • Fig. 33 Global aesthesia devices market: Regional outlook and key takeaways
  • Fig. 34 Global anesthesia devices market share and leading players
  • Fig. 35 North America market share and leading players
  • Fig. 36 Europe market share and leading players
  • Fig. 37 Asia Pacific market share and leading players
  • Fig. 38 Latin America market share and leading players
  • Fig. 39 Middle East & Africa market share and leading players
  • Fig. 40 North America market estimates and forecasts, 2021 - 2033
  • Fig. 41 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 42 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 43 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 44 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 45 UK market estimates and forecasts, 2021 - 2033
  • Fig. 46 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 47 France market estimates and forecasts, 2021 - 2033
  • Fig. 48 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 49 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 50 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 51 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 52 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 53 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 54 China market estimates and forecasts, 2021 - 2033
  • Fig. 55 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 56 India market estimates and forecasts, 2021 - 2033
  • Fig. 57 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 58 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 59 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 60 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 61 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 62 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 63 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 64 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 65 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 66 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 67 Kuwait market estimates and forecasts, 2021 - 2033
  • Fig. 68 Market share of key market players- aesthesia devices market
  • Fig. 69 Key Company Categorization
  • Fig. 70 Company Market Share/Position Analysis, 2025
  • Fig. 71 Strategic Framework